News Daily News To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke Todd Neale October 03, 2023
News Daily News MESA Data Can Lend Context to Incidental CAC Findings Yael L. Maxwell September 29, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters Shelley Wood September 28, 2023
News Daily News Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry Michael O'Riordan September 27, 2023
News Daily News Patient ‘Progressing Well’ After Second Pig-to-Human Heart Transplant Yael L. Maxwell September 26, 2023
News Daily News Many Young Patients With AR Do Not Achieve LV Normalization With Surgery L.A. McKeown September 26, 2023
News Daily News Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF Michael O'Riordan September 25, 2023
News Daily News Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted? Michael O'Riordan September 21, 2023
News Daily News CRT With His-Purkinje Conduction System Pacing Succeeds in Pilot RCT Todd Neale September 20, 2023
News Daily News AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons L.A. McKeown September 20, 2023
News Daily News Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA Todd Neale September 19, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes Caitlin E. Cox September 18, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News Cardiac MR Noninferior to CT for TAVI Planning, Small RCT Shows Yael L. Maxwell September 15, 2023
News Daily News ‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease Michael O'Riordan September 13, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023